Zhitong Finance App News, Yingpai Pharmaceutical-B (07630.HK) issued an announcement. The board of directors was informed by Dr. Choi Suixiong, the company's executive director and CEO, that it had recently purchased a total of 100,000 shares of the company's common shares on the open market. The average price per share is about HK$14.6105, accounting for about 0.035% of the total number of shares issued by the company. Following the purchase, Dr. Choi held an interest in a total of 185.409 million shares, accounting for approximately 6.564% of the total issued share capital of the Company as of the date of this announcement.

Zhitong Finance App News, Yingpai Pharmaceutical-B (07630.HK) issued an announcement. The board of directors was informed by Dr. Choi Suixiong, the company's executive director and CEO, that it had recently purchased a total of 100,000 shares of the company's common shares on the open market. The average price per share is about HK$14.6105, accounting for about 0.035% of the total number of shares issued by the company. Following the purchase, Dr. Choi held an interest in a total of 185.409 million shares, accounting for approximately 6.564% of the total issued share capital of the Company as of the date of this announcement.